Multi-cancer blood test missed key goal in NHS trial
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"I am genuinely very excited about the reduction in stage four cancers."
— Prof Charles Swanton , Academic
"Without mortality data and a transparent account of harms, claims of population benefit from multi-cancer early detection remain speculative."
— Prof Richard Houlston , Academic
Key People
Locations
All Coverage
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Similar Stories
Related coverage based on topic and tags
Vaccine breakthrough stops cancer returning in trial
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
August 19, 2026 at 07:00 PMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMModerna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026 at 09:01 PMVIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results Reuters
August 19, 2026 at 02:45 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMI went for a full body MOT and the results came as a shock
The private body scan industry is booming, but is it doing more harm than good?
August 8, 2026 at 12:49 AM